Robotic Surgery for Gynecologic Cancers
Explore cutting-edge robotic surgical techniques for gynecologic cancers, their advantages, and outcomes. Learn about minimally invasive procedures, enhanced imaging, and future developments in this field.
Fluid-Based Biomarkers for Ovarian and Prostate Cancer - Winter 2021
Explore fluid-based biomarkers for ovarian and prostate cancer with Prof. Kislinger. Learn about shotgun proteomics, sample types, and cutting-edge research in cancer detection.
Immunotherapy for Gynecological Cancers
Explore current immunotherapy progress for gynecological cancers, including clinical trial data and promising new approaches for ovarian, endometrial, and cervical cancer treatment.
Dr. Oliver Dorigo on Ovarian Cancer - Current & Novel Treatment Strategies
Explore advancements in ovarian cancer diagnosis and treatment, including specialized approaches based on cancer location and cellular anatomy, with insights from Dr. Oliver Dorigo of Stanford University.
Personalizing Ovarian Cancer- Knowing Your Genetics - Beth Karlan, MD - UCLAMDChat
Comprehensive overview of ovarian cancer, covering genetics, testing, treatments, and risk reduction. Explores targeted therapies, PARP inhibitors, and importance of family history in personalized care.
Advanced Ovarian Cancer - Diagnosis, Treatment and Future Directions
Explore comprehensive insights into advanced ovarian cancer, from diagnosis and genetic testing to treatment strategies, side effect management, and future research directions.
The Promise of Early Cancer Screening - Innovations and Challenges
Explore innovations in early cancer detection, addressing screening challenges, healthcare disparities, and the impact of new technologies on public health and cancer prevention strategies.
Triaging Suspicious Adnexal Masses: Should I Be Worried About Ovarian Cancer, and Can Biomarkers Help?
Explore early detection methods for epithelial ovarian cancer, addressing diagnostic challenges and the potential role of biomarkers in improving patient outcomes and resource allocation.
Cytokine Armored CAR NK Cell Therapy for Advanced Ovarian Cancer
Explore innovative CAR NK cell therapy for ovarian cancer using non-viral transposon engineering and CRISPR/Cas9 editing. Learn about advancements in immunotherapy and potential applications in solid tumors.
Epithelial-Mesenchymal Transition in Cancer - Novel Treatments for Drug Resistant and Metastatic Cells
Explore novel treatments targeting epithelial-mesenchymal transition to combat drug resistance and metastasis in cancer, focusing on recent developments and therapeutic potential.
Designer Nanocarriers for Cancer Therapy
Explore cutting-edge nanocarrier designs for targeted cancer therapy, focusing on ovarian cancer treatment and innovative drug delivery mechanisms.
A Discussion on Gynecological Cancers: Cervical, Ovarian, and Uterine
Explore gynecological cancers with expert insights on cervical, ovarian, and uterine cancers, their diagnosis, and impact on women's health.
PennChart Genomics Initiative at Five Years: From Integration to Implementation
Explore the PennChart Genomics Initiative's progress in integrating and implementing genomics in healthcare, presented by renowned cancer genetics expert Dr. Katherine Nathanson.
Understanding GWAS Mechanisms with Transcriptome-Wide Association Studies
Explore GWAS mechanisms through Transcriptome-Wide Association Studies. Learn to identify genetic determinants of chromatin and quantify genetic effects on disease mediated by gene expression levels.
Implementing CGP and HRD Testing In-House for Advanced Cancer Care
Explore implementing CGP and HRD testing in healthcare, covering technical aspects, concordance with other assays, and benefits of in-house testing for matching patients with therapies.
Cancer Genomics Consortium 2023 Webinar Series - CGC 2022 Annual Meeting Poster Winners
Explore cutting-edge cancer genomics research, focusing on childhood brain tumors and ovarian cancer. Gain insights into copy number alterations, single-cell RNA sequencing, and their impact on patient outcomes.
Beyond CNVs: Leveraging SNP Arrays in Cancer
Explore leveraging SNP arrays in cancer genomics beyond CNVs, focusing on mosaic gains/losses, HRD scores, and noninformative SNPs for improved diagnosis and treatment.
HRD Evaluation and Scoring Using OncoScan CNV Assay - A Whole-Genome Microarray Research Solution
Explore HRD evaluation and scoring using OncoScan CNV Assay, a whole-genome microarray research solution for detecting genome-wide biomarkers in ovarian and breast cancers.
HRD Evaluation and Scoring Using OncoScan CNV Assay - A Whole-Genome Microarray Research Solution
Explore HRD evaluation and scoring using OncoScan CNV Assay, a whole-genome microarray solution for cancer research, focusing on PARP inhibitors and synthetic lethality in tumors.
How to Translate Complex Genomic Data to Clinically-Oriented Personalized Cancer Care
Explore real-world application of translating complex genomic data into personalized cancer care, focusing on NGS testing and variant interpretation for hereditary cancers.
De-escalating PARP Inhibitor Maintenance Therapy in Ovarian Cancer Using Adaptive Therapy
Explore innovative approaches to PARP inhibitor maintenance therapy in ovarian cancer, focusing on adaptive treatment strategies and de-escalation methods for optimal patient outcomes.